Yoichi Naito

42PUBLICATIONS
191CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsEpidemiological methodsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (42)

|Sep 11, 2026
Treatment patterns after first-line abemaciclib therapy in patients with HR+, HER2- metastatic breast cancer in Japan.

|Sep 03, 2026
Molecularly Guided Therapy Versus Continued Chemotherapy in Unfavorable Cancer of Unknown Primary: Updated Efficacy and Safety From the Randomized, Phase II CUPISCO Study.

|Aug 17, 2026
De-escalation of perioperative systemic therapy for early breast cancer.

|Aug 12, 2026
Current perspectives on circulating tumor DNA in breast cancer: a narrative review.

|Jul 01, 2026
De-escalation of breast surgery for early stage breast cancer.

|Mar 26, 2026
Sacituzumab govitecan in Japanese participants with HR+/HER2- metastatic breast cancer: primary results from the phase II ASCENT-J02 study.

Akihiko Shimomura, Takahiro Kogawa, Koji Matsumoto

Pageof 7

Frequent Collaborators

7 joint publications

Nobuaki Matsubara

6 joint publications

Hideaki Bando

5 joint publications

Akihiko Shimomura

4 joint publications

Toru Mukohara